Free Access to TSR Screeners - Sign Up for Your Nightly Pass
Stock Analysis of Balaxi Pharmaceuticals Ltd. (BALAXI) - Birds Eye View
Overview
Code | BALAXI |
Close | 51.95 |
Change | 0.920 / 1.80 % |
Volume | 116657 |
Vol Change | -5234.00 / 4.29 % |
Industry | Misc Fin Services |
Sector | Financial |
TSR Strength Index
Technical Strength | Neutral |
Growth Index | Low Growth Stock |
Value Index | Good Value |
Profitability Index | Very Low Profitability Stock |
Stability Index | Excellent Stability |
Fundamental View of Balaxi Pharmaceuticals Ltd.
PE (TTM)
9.14
ExcellentPrice / Book
1.26
GoodPrice / Sales
0.783
Very GoodPiotroski F Score
5.0
IndecisiveMarket Cap
264.46 (Cr)
Enterprise Value
221.57 (Cr)
ROA (TTM)
11.47
GoodROE (TTM)
15.02
GoodNet Margin (TTM)
8.57
Not GoodRevenue
28.28 %
2412.90 MNet Profit
105.20 %
-23900.00 KDebt to Equity
0.096
ExcellentAltman Z Score
5.58
ExcellentQuick Ratio
2.36
GoodCash Ratio
1.15
IndecisiveHighs/Lows of Balaxi Pharmaceuticals Ltd.
Period | Old price | Stock Return | Nifty 50 | High | Low | High Date | Low Date |
---|---|---|---|---|---|---|---|
One Week | 49.99 | 3.92 % | 1.02 % | 57.24 | 50.66 | 02-Jun-25 | 04-Jun-25 |
Two Week | 52.98 | 1.94 % | 0.603 % | 57.24 | 49.20 | 02-Jun-25 | 30-May-25 |
One Month | 52.81 | 1.63 % | 2.56 % | 57.92 | 49.20 | 19-May-25 | 30-May-25 |
Three Month | 59.88 | 13.24 % | 10.90 % | 76.10 | 49.20 | 12-Mar-25 | 30-May-25 |
Six Months | 84.12 | 38.24 % | 1.32 % | 85.58 | 49.20 | 09-Dec-24 | 30-May-25 |
One year | 106.50 | 51.22 % | 9.56 % | 133.00 | 49.20 | 18-Jun-24 | 30-May-25 |
Two year | 106.64 | 51.28 % | 34.43 % | 151.45 | 49.20 | 30-May-24 | 30-May-25 |
Five year | 21.83 | 137.98 % | 146.53 % | 216.04 | 21.47 | 14-Oct-20 | 09-Jun-20 |
Technical View of Balaxi Pharmaceuticals Ltd.
RSI
41.66
NeutralMACD
-1.80
BullishADX
16.32
NeutralSuper Trend
56.89
Mild BearishWilliams %R
-65.80
NeutralCCI
-74.36
NeutralEMA 5
51.58
Mild BullishEMA 15
52.34
BearishEMA 50
56.95
Mild BearishEMA 100
63.12
Mild BearishSMA 100
62.12
Strong BearishSMA 200
77.15
Strong BearishSMA 5 / 20
51.87 / 52.91
Mild BearishSMA 15 / 50
52.15 / 58.35
Mild BearishSMA 50 / 200
58.35 / 77.15
Mild BearishCharts of Balaxi Pharmaceuticals Ltd.
Compare Fundamentals of Balaxi Pharmaceuticals Ltd. with Peers
Ratio / Stock | BALAXI | MANBA | STARTECK | WORTH |
PE | 9.14 | 0 | 27.24 | 12.50 |
P/B | 1.26 | 0 | 1.29 | 1.77 |
ROA | 11.47 | 0 | 2.18 | 15.52 |
ROE | 15.02 | 0 | 4.73 | 14.79 |
Debt To Equity | 0.096 | 0 | 0.968 | 0.059 |
Revenue | 2412.90 M 28.28 % | 1915.90 M 43.71 % | 327109 K 47.41 % | 2384.60 M 19.84 % |
Net Income | -23900.00 K 105.20 % | 311800 K 105.00 % | 0 100.00 % | 158800 K 12.07 % |
About : BALAXI PHARMACEUTICALS LIMITED
Address : Maps Towers, Hyderabad, India, 500096
Tel : 91 40 2355 5300
URL : https://balaxipharma.in
Code : BALAXI, ISIN : INE618N01022, Exchange : NSE, Country : India
Fiscal Year End : March
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. Balaxi Pharmaceuticals Limited was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.